Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 6: COVID-19 and the Eye
Submit an article Journal homepage
178
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

A Curious Case of Occlusive Retinal Vasculitis in a Young Individual Associated with COVID-19 Vaccination

Priya R. ChandrasekaranDepartment of Medical Retina, Uvea and Neuro-ophthalmology, Lotus Eye Hospital, Coimbatore, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2393-1329View further author information
, MBBS, DO, DNB, FRCS (Glasgow)ORCID Icon
Pages 1254-1260 | Received 30 Apr 2022, Accepted 10 Oct 2022, Published online: 28 Oct 2022

References

  • Talat L, Lightman S, Tomkins-Netzer O. Ischemic retinal vasculitis and its management. J Ophthalmol. 2014;2014:1–13. doi:10.1155/2014/197675.
  • Agarwal A, Keefe O, Tripathy K, Palestine A, Lim JI. Retinal vasculitis. EyeWiki; 2021. https://eyewiki.aao.org/Retinal_Vasculitis
  • Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354(9176):407–413. doi:10.1016/S0140-6736(98)11058-9.
  • Huang X, Yang Y, Duan Y, Kuang YQ, Lin D. Homocysteine in retinal artery occlusive disease - A meta-analysis of cohort studies. Sci Rep. 2017;7(1):15708. doi:10.1038/s41598-017-16065-2.
  • El-Asrar AMA, Abdel Gader AGM, Al-Amroi SA, Al Attas OS. Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol. 2002;12(6):495–500. doi:10.1177/112067210201200608.
  • Suvajac G, Stojanovich L, Milenkovich S. Ocular manifestations in antiphospholipid syndrome. Autoimmun Rev. 2007;6(6):409–414. doi:10.1016/j.autrev.2006.11.005.
  • Uludag G, Onghanseng N, Tran ANT, et al. Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations. J Ophthalmic Inflamm Infect. 2021;11(1):11. doi:10.1186/s12348-021-00240-8.
  • Radwan A, Metzinger JL, Hinkle DM, Foster CS. Cytomegalovirus retinitis in immunocompetent patients: case reports and literature review. Ocular Immunol Inflammation. 2013;21(4):324–328. doi:10.3109/09273948.2013.786095.
  • Pathanapitoon K, Tesavibul N, Choopong P, et al. Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection. JAMA Ophthalmol. 2013;131(5):638–645. doi:10.1001/jamaophthalmol.2013.2860.
  • Tabatabaei SA, Cheraqpour K, Pour EK, Sefidan BB. Long-term prophylaxis in an immunocompetent patient with Cytomegalovirus retinitis: a case report and review of literature. J Ophthalmic Inflamm Infect. 2020;10(1):16. doi:10.1186/s12348-020-00207-1.
  • Kharel R, Iyer V, Noronha V, Majumder PD, Biswas J. Role of high-resolution computerized tomography chest in identifying tubercular etiology in patients diagnosed as Eales’Disease. J Ophthalmic Inflamm Infect. 2017;7(4):1–6. doi:10.1186/s12348-016-0120-1.
  • Gupta P, Biswas J. Further evidence of the association of latent Mycobacterium tuberculosis in Eales disease. Int Ophthalmol. 2021;41(3):901–906. doi:10.1007/s10792-020-01645-5.
  • Rajpal SUB, Mohapatra S, Wagh VK, Porwal C, Kaushik A. Association of mycobacterium tuberculosis in the causation of Eales’ disease: an institutional experience. Indian J Med Microbiol. 2015;33:S43–45.
  • Pang K, Pan L, Guo H, Wu X. Case Report: associated ocular adverse reactions with inactivated COVID-19 vaccination in China. Front Med (Lausanne). 2022;8:1–6. doi:10.3389/fmed.2021.823346.
  • Lee YK, Huang YH. Ocular manifestations after receiving COVID-19 vaccine: a systematic review. Vaccines (Basel). 2021;9:1–14. doi:10.3390/vaccines9121404.
  • See I, Su JR, Lale A, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination. JAMA. 2021;325(24):2448–2456. doi:10.1001/jama.2021.7517.
  • Neri P, Pichi F. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights. Int Ophthalmol. 2020;40(5):1057–1060. doi:10.1007/s10792-020-01389-2.
  • Jampol LM, Tauscher R, Schwarz HP. COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina causation or coincidence? JAMA Ophthalmol. 2021;139(10):1135–1136. doi:10.1001/jamaophthalmol.2021.3483.
  • Neri P, Pichi F. SARS-CoV-2 and the eye: the pandora’s box of ocular immunology. J Ocul Pharmacol Ther. 2021;37(9):502–509. doi:10.1089/jop.2021.0058.
  • Interim recommendations for use of the ChAdOx1-S (recombinant) vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD 1222 VaxzevriaTM, SII CovishieldTM.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.